MK2206 (5 μm) effectively inhibited the phosphorylation of AKT (Fig. 4A) and caused mesenchymal HCC cells induced by IL‐17A to revert to an epithelial phenotype (Fig. S4A). This evidence concerns the gene AKT1 and hepatocellular carcinoma.